Management & Regulatory

How Will ChargePoint's New Liverpool Facility Boost Pharma Tech?
Management & Regulatory How Will ChargePoint's New Liverpool Facility Boost Pharma Tech?

ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position

Inflation Reduction Act's Impact on Healthcare and Equity
Management & Regulatory Inflation Reduction Act's Impact on Healthcare and Equity

The Inflation Reduction Act (IRA) marks a significant milestone in U.S. healthcare reform, particularly for those covered by Medicare. This comprehensive legislation introduces an array of policy changes poised to transform numerous sectors within the healthcare industry. One of the most crucial

Moderna and OpenAI Forge AI Path in Vaccine Development
Management & Regulatory Moderna and OpenAI Forge AI Path in Vaccine Development

In a groundbreaking initiative, Moderna has joined forces with AI powerhouse OpenAI to revolutionize vaccine development through artificial intelligence. This move signifies a fusion of Moderna's medical prowess with OpenAI's advanced AI technology. Together, they seek to transform the

Biopharma Industry Faces Wave of Layoffs Amidst Restructuring
Management & Regulatory Biopharma Industry Faces Wave of Layoffs Amidst Restructuring

The biopharmaceutical industry is currently navigating through turbulent waters as a series of layoffs and strategic overhauls ripple across the sector. The urgency that once underscored the COVID-19 pandemic has given way to a new reality where pharmaceutical giants are reassessing their

BioNTech Launches Modular mRNA Vaccine Facility in Rwanda
Management & Regulatory BioNTech Launches Modular mRNA Vaccine Facility in Rwanda

BioNTech, the German biotechnology company known for its pivotal role in creating a COVID-19 vaccine with Pfizer, has inaugurated a state-of-the-art modular mRNA vaccine production facility in Kigali, the capital of Rwanda. This initiative marks a significant step toward health equality and local

Eli Lilly Acquires Nexus Facility to Boost Drug Production
Management & Regulatory Eli Lilly Acquires Nexus Facility to Boost Drug Production

Eli Lilly is making a significant move to fortify its global network for manufacturing parenteral products by acquiring a facility from Nexus Pharmaceuticals. This strategic step is set to greatly enhance Lilly's ability to supply its growing number of medications and underscores a commitment

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later